Brief: Neurosense Regains Compliance With Nasdaq MBP Rule

Neurosense Therapeutics

07/02/2024 14:30

Feb 7 (Reuters) - Neurosense Therapeutics Ltd  NRSN.O :
    * NEUROSENSE REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID
PRICE RULE
    * NEUROSENSE THERAPEUTICS LTD - LOOKING FORWARD TO REPORTING
RESULTS FROM OUR COLLABORATION WITH BIOGEN IN COMING WEEKS

Source text for Eikon:  ID:nPn7V7j0sa 
Further company coverage:  NRSN.O 

 ((Reuters.Briefs@thomsonreuters.com;))